ConductScience.org, home
Papers
API referenceFor AI assistants

Paper820241

In vitro evaluation of cefoxitin and cefamandole.

Adams HG and 2 others. Antimicrob Agents Chemother, 1976. Cited by 36 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro evaluation of cefoxitin and cefamandole. Papers, record 820241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/820241

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro evaluation of cefoxitin and cefamandole.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
2.27
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Adams HGH G
2Stilwell GAG A
3Turck MM

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CefoxitinMajor topic
CephalosporinsMajor topic
Drug Resistance, Microbial
Enterobacteriaceae
Mandelic Acids
Microbial Sensitivity Tests
Pseudomonas aeruginosa

Source PubMed

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,828,189Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15828189PubMed
215,828,188Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15828188PubMed
314,322,849LABORATORY AND CLINICAL EVALUATION OF A NEW ANTIBIOTIC--CEPHALOTHIN.Ann Intern Med1965https://conductscience.org/library/papers/14322849PubMed
45,325,707Antibiotic susceptibility testing by a standardized single disk method.Am J Clin Pathol1966https://conductscience.org/library/papers/5325707PubMed
54,599,124Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4599124PubMed
64,840,447Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4840447PubMed
74,790,616Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790616PubMed
84,790,605Evaluation of cefazolin, a new cephalosporin antibiotic.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790605PubMed
91,137,364Susceptibility of anaerobes to cefoxitin and other cephalosporins.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1137364PubMed

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
7,396,456Clinical and pharmacokinetic evaluation of parental cefoxitin in infants and children.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7396456PubMed
6,999,021Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.J Clin Microbiol1980https://conductscience.org/library/papers/6999021PubMed
6,762,896The third generation cephalosporins.Bull N Y Acad Med1982https://conductscience.org/library/papers/6762896PubMed
6,285,810Cefotaxime therapy of serious bacterial infection in adults.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6285810PubMed
6,214,994Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6214994PubMed
856,727[In vitro susceptibility of bacteroidaceae to cefoxitin and cephalothin (author's transl)].Infection1977https://conductscience.org/library/papers/856727PubMed
526,006LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/526006PubMed
400,821In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/400821PubMed
369,806Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.Drugs1979https://conductscience.org/library/papers/369806PubMed
324,399Cefazaflur, a new parenteral cephalosporin: in vitro studies.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/324399PubMed
314,270Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/314270PubMed
112,919Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/112919PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/820241

GET https://conductscience.org/api/papers/v1/820241/authors

API referenceFor AI assistants